Related references
Note: Only part of the references are listed.ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling
Chengjian Guan et al.
ONCOGENE (2020)
Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor
Sophia G. Liva et al.
EMBO MOLECULAR MEDICINE (2020)
MiR-193a-3p inhibits pancreatic ductal adenocarcinoma cell proliferation by targeting CCND1
Zhi-Min Chen et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder cancer
Marie-Lisa Eich et al.
TRANSLATIONAL ONCOLOGY (2019)
Degradative autophagy selectively regulates CCND1 (cyclin D1) and MIR224, two oncogenic factors involved in hepatocellular carcinoma tumorigenesis
Shan-Ying Wu et al.
AUTOPHAGY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cell Cycle Regulation by Alternative Polyadenylation of CCND1
Qiong Wang et al.
SCIENTIFIC REPORTS (2018)
Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma
Q. A. Yu et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Fucosylation Deficiency in Mice Leads to Colitis and Adenocarcinoma
Yiwei Wang et al.
GASTROENTEROLOGY (2017)
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma
Derek Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
One-carbon metabolism in cancer
Alice C. Newman et al.
BRITISH JOURNAL OF CANCER (2017)
Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway
Gregory S. Ducker et al.
CELL METABOLISM (2016)
Targeting MTH FD2 in acute myeloid leukemia
Yana Pikman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1
Cheng-Cao Sun et al.
ONCOTARGET (2016)
Notch2 as a promising prognostic biomarker for oesophageal squamous cell carcinoma
Cong Wang et al.
SCIENTIFIC REPORTS (2016)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
The folate-coupled enzyme MTHFD2 is a nuclear protein and promotes cell proliferation
Nina Gustafsson Sheppard et al.
SCIENTIFIC REPORTS (2015)
The current role of targeted therapies to induce radioiodine uptake in thyroid cancer
Eleonore Froehlich et al.
CANCER TREATMENT REVIEWS (2014)
Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
Roland Nilsson et al.
NATURE COMMUNICATIONS (2014)
NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma
Giulio Fiaschetti et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
Siwanon Jirawatnotai et al.
NATURE (2011)
Molecular classification and biomarker discovery in papillary thyroid carcinoma
O Sheils
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2005)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
Share Paper
